导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | 9.95% | 130/354 |
| 近一周 | -1.59% | 162/356 |
| 近一月 | -3.46% | 214/362 |
| 近一季 | -2.98% | 228/362 |
| 近半年 | 16.08% | 94/358 |
| 近一年 | 13.51% | 125/349 |
| 近两年 | 37.26% | 132/314 |
| 近三年 | 68.28% | 52/244 |
| 成立以来 | 745.89% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
-7.56% 233/360 |
25.08% 49/366 |
- - |
- - |
| 2025 | 15.44% 225/358 |
-8.82% 298/340 |
16.65% 48/348 |
7.67% 198/354 |
0.81% 147/358 |
| 2024 | 24.57% 48/329 |
8.16% 68/280 |
8.06% 57/310 |
0.04% 247/318 |
6.54% 40/329 |
| 2023 | 54.14% 11/275 |
18.46% 24/205 |
20.26% 16/230 |
-3.67% 87/262 |
12.32% 52/276 |
| 2022 | -28.23% 135/201 |
-8.84% 69/153 |
-19.76% 141/164 |
0.23% 36/189 |
-2.10% 170/202 |
| 2021 | 24.56% 25/150 |
2.23% 127/312 |
9.67% 65/328 |
1.52% 33/358 |
9.43% 31/151 |
| 2020 | 34.37% 19/103 |
-10.94% 134/280 |
29.56% 39/295 |
7.98% 67/299 |
7.85% 160/305 |
| 2019 | 39.87% 4/88 |
14.41% 54/258 |
6.23% 15/268 |
3.75% 45/253 |
10.92% 51/266 |
| 2018 | 3.84% 7/79 |
- - |
- - |
- - |
-17.63% 199/241 |
| 2017 | 23.02% 23/69 |
- - |
- - |
- - |
- - |
| 2016 | 10.89% 16/59 |
- - |
- - |
- - |
- - |
| 2015 | 17.19% 1/49 |
- - |
- - |
- - |
- - |
| 2014 | 16.13% 11/99 |
- - |
- - |
- - |
- - |
| 2013 | 29.53% 4/70 |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 广发中证香港创新药ETF(QDII) | 1.2744 | 27.49% |
| 广发道琼斯石油指数美元现汇A | 0.4802 | 27.44% |
| 广发道琼斯石油指数美元现汇C | 0.4718 | 27.38% |
| 广发道琼斯石油指数(QDII-LOF)美元现汇E | 0.4729 | 27.33% |
| 广发道琼斯石油指数人民币A | 3.2498 | 26.68% |
| 广发道琼斯石油指数人民币C | 3.1927 | 26.58% |
| 广发道琼斯石油指数(QDII-LOF)人民币E | 3.2003 | 26.55% |
| 广发中证香港创新药ETF发起式联接(QDII)C | 1.3286 | 26.01% |
| 富国标普石油天然气勘探及生产精选行业ETF(QDII) | 1.4105 | 25.68% |
| 汇添富恒生生物科技ETF(QDII) | 1.1055 | 25.31% |
| 广发纳斯达克100ETF联接人民币(QDII)A VS. 建信富时100指数(QDII)人民币A(539003) |